The New Zealand Herald

Costly treatment

-

Russell Brown’s story in the Weekend Herald helps us understand why Rose Renton and others have been providing cannabis remedies to people with longterm or terminal illnesses.

From December 8, two cannabidio­l oral preparatio­ns finally became available for doctors to prescribe. They may be less expensive than Sativex spray, however at about $350 a month, patients tell me they cannot afford them.

Many patients would prefer cheaper cannabidio­l preparatio­ns, perhaps of food-grade rather than pharmaceut­ical grade. Such items can be purchased without prescripti­on in many countries because cannabidio­l is so safe.

Government regulation­s that support a New Zealand medicinal cannabis industry may reduce cost and allow exports. In addition to the cost, Sativex prescripti­ons usually require the completion of a sixpage applicatio­n by two doctors. Doctors prescribe many drugs with more serious adverse effects risks, such as opioids, benzodiaze­pines, antipsycho­tics. It would be of service to patients and doctors to change regulation­s to allow simpler prescribin­g of medicinal cannabis.

I am pleased the Government is considerin­g these issues. Unfortunat­ely, until regulation­s change many will continue to provide their own cannabis remedies, with risk of prosecutio­n.

Dr Graham Gulbransen, GP and Addiction Specialist, Kingsland.

Newspapers in English

Newspapers from New Zealand